Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial
Federico Pulido, Andrew Ustianowski, Adrián Curran, Georg M. N. Behrens et al.
Journal
The Lancet Infectious Diseases
Topics
HIV/AIDS drug development and treatment
article
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial
Federico Pulido, Andrew Ustianowski, Adrián Curran, Georg M. N. Behrens, Lisa Hamzah, Christine Katlama, Geoffroy Liégeon, Brenda Crabtree, Jack Moody, Pere Domingo, Julie Fox, Andrea Antinori, Hernando Knobel, Phil Bright, Nikos Dedes, Christoph D. Spinner, Jean‐Michel Molina, Anton Pozniak, Francesco Genderini, Joaquín Portilla, Jürgen K. Rockstroh, Gema Jiménez, Chris Kenyon, Aoife G. Cotter, Frank A. Post, Karine Lacombe, Estebán Martínez, Janina Trauth, Lambert Assoumou, Roya Movahedi, Robert F. Miller, Alberto Díaz de Santiago, Antonella Castagna, Rafael Micán, Monserrat Laguno, Juan González, François Raffi, Carl Fletcher
article en
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Infectious Diseases
Institutions
Inserm (FR), Université Paris Cité (FR), University Hospital Bonn (DE), Hospital Universitario La Paz (ES), Hospital de Sant Pau (ES), Medizinische Hochschule Hannover (DE), Sorbonne Université (FR), Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IT), King's College Hospital NHS Foundation Trust (GB), St George's Hospital (GB), Hospital Clínic de Barcelona (ES), Hôpital Lariboisière (FR), Vall d'Hebron Hospital Universitari (ES), Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR), Chelsea and Westminster Hospital (GB), Centre for Individualised Infection Medicine (DE), Centre Hospitalier Universitaire de Saint-Pierre (BE)